_id
69148a23ccc777a4e85d98cb
Ticker
PASG
Name
Passage Bio Inc
Exchange
NASDAQ
Address
One Commerce Square, Philadelphia, PA, United States, 19103
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.passagebio.com
Description
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Last Close
10.68
Volume
19519
Current Price
9.98
Change
-6.554307116104862
Last Updated
2025-12-03T11:48:54.624Z
Image
-
Ipo Date
2020-02-28T00:00:00.000Z
Market Cap
25525040
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.864
Sentiment Sources
3
Rating
5
Target Price
39.6
Strong Buy
5
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
8655000
Operating Income
-8655000
Interest Expense
-
Pretax Income
-7749000
Net Income
-7749000
Eps
-2.4453025671416846
Dividends Per Share
-
Shares Outstanding
3178710
Income Tax Expense
-
EBITDA
-7439000
Operating Margin
-
Total Other Income Expense Net
906000
Cash
52773000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
55730000
Property Plant Equipment
18160000
Total Assets
74160000
Payables
952000
Short Term Debt
3542000
Long Term Debt
-
Total Liabilities
43040000
Equity
31120000
Depreciation
200000
Change In Working Capital
2104000
Cash From Operations
-4853000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-4853000
PE
-
PB
1.016258076478149
ROE
-24.900385604113108
ROA
-10.449029126213592
FCF
-4853000
Fcf Percent
-
Piotroski FScore
1
Health Score
33
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
2.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
4
Quality Investing Score
1.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
8655000
Quarters > 0 > income Statement > operating Income
-8655000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-7749000
Quarters > 0 > income Statement > net Income
-7749000
Quarters > 0 > income Statement > eps
-2.4453025671416846
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
3168933
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-7439000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
906000
Quarters > 0 > balance Sheet > cash
52773000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
55730000
Quarters > 0 > balance Sheet > property Plant Equipment
18160000
Quarters > 0 > balance Sheet > total Assets
74160000
Quarters > 0 > balance Sheet > payables
952000
Quarters > 0 > balance Sheet > short Term Debt
3542000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
43040000
Quarters > 0 > balance Sheet > equity
31120000
Quarters > 0 > cash Flow > net Income
-7749000
Quarters > 0 > cash Flow > depreciation
200000
Quarters > 0 > cash Flow > change In Working Capital
2104000
Quarters > 0 > cash Flow > cash From Operations
-4853000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-4853000
Quarters > 0 > ratios > PE
-2.4453025671416846
Quarters > 0 > ratios > PB
1.016258076478149
Quarters > 0 > ratios > ROE
-24.900385604113108
Quarters > 0 > ratios > ROA
-10.449029126213592
Quarters > 0 > ratios > FCF
-4853000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
200000
Quarters > 1 > income Statement > gross Profit
-200000
Quarters > 1 > income Statement > operating Expenses
10134000
Quarters > 1 > income Statement > operating Income
-10334000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-9385000
Quarters > 1 > income Statement > net Income
-9385000
Quarters > 1 > income Statement > eps
-2.9615646654567955
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
3168933
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-9185000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
949000
Quarters > 1 > balance Sheet > cash
57626000
Quarters > 1 > balance Sheet > short Term Investments
0
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
60315000
Quarters > 1 > balance Sheet > property Plant Equipment
18613000
Quarters > 1 > balance Sheet > total Assets
79198000
Quarters > 1 > balance Sheet > payables
2395000
Quarters > 1 > balance Sheet > short Term Debt
3592000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
40940000
Quarters > 1 > balance Sheet > equity
38258000
Quarters > 1 > cash Flow > net Income
-9385000
Quarters > 1 > cash Flow > depreciation
169000
Quarters > 1 > cash Flow > change In Working Capital
1949000
Quarters > 1 > cash Flow > cash From Operations
-6330000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
585000
Quarters > 1 > cash Flow > cash From Financing
14000
Quarters > 1 > cash Flow > net Change In Cash
-5731000
Quarters > 1 > ratios > PE
-2.9615646654567955
Quarters > 1 > ratios > PB
0.826649363270427
Quarters > 1 > ratios > ROE
-24.530817084008575
Quarters > 1 > ratios > ROA
-11.850046718351473
Quarters > 1 > ratios > FCF
-6330000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
32
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
201000
Quarters > 2 > income Statement > gross Profit
-201000
Quarters > 2 > income Statement > operating Expenses
16459000
Quarters > 2 > income Statement > operating Income
-16459000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-15405000
Quarters > 2 > income Statement > net Income
-15405000
Quarters > 2 > income Statement > eps
-4.960553856061826
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3105500
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-13621000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1054000
Quarters > 2 > balance Sheet > cash
63357000
Quarters > 2 > balance Sheet > short Term Investments
0
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
66669000
Quarters > 2 > balance Sheet > property Plant Equipment
19063000
Quarters > 2 > balance Sheet > total Assets
86006000
Quarters > 2 > balance Sheet > payables
1458000
Quarters > 2 > balance Sheet > short Term Debt
3641000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
39300000
Quarters > 2 > balance Sheet > equity
46706000
Quarters > 2 > cash Flow > net Income
-15405000
Quarters > 2 > cash Flow > depreciation
201000
Quarters > 2 > cash Flow > change In Working Capital
-2267000
Quarters > 2 > cash Flow > cash From Operations
-13847000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
39631000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
25784000
Quarters > 2 > ratios > PE
-4.960553856061826
Quarters > 2 > ratios > PB
0.6635740590074081
Quarters > 2 > ratios > ROE
-32.982914400719395
Quarters > 2 > ratios > ROA
-17.91154105527521
Quarters > 2 > ratios > FCF
-13847000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
38
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
3212000
Quarters > 3 > income Statement > cost Of Revenue
719000
Quarters > 3 > income Statement > gross Profit
-719000
Quarters > 3 > income Statement > operating Expenses
13551000
Quarters > 3 > income Statement > operating Income
-14270000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-12725000
Quarters > 3 > income Statement > net Income
-12725000
Quarters > 3 > income Statement > eps
-4.100737971705714
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3103100
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-12306000
Quarters > 3 > income Statement > operating Margin
-444.2714819427148
Quarters > 3 > income Statement > total Other Income Expense Net
1545000
Quarters > 3 > balance Sheet > cash
37573000
Quarters > 3 > balance Sheet > short Term Investments
39183000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
78815000
Quarters > 3 > balance Sheet > property Plant Equipment
23134000
Quarters > 3 > balance Sheet > total Assets
102412000
Quarters > 3 > balance Sheet > payables
742000
Quarters > 3 > balance Sheet > short Term Debt
3688000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
41151000
Quarters > 3 > balance Sheet > equity
61261000
Quarters > 3 > cash Flow > net Income
-12725000
Quarters > 3 > cash Flow > depreciation
719000
Quarters > 3 > cash Flow > change In Working Capital
2680000
Quarters > 3 > cash Flow > cash From Operations
-8444000
Quarters > 3 > cash Flow > capital Expenditures
14000
Quarters > 3 > cash Flow > cash From Investing
13678000
Quarters > 3 > cash Flow > cash From Financing
47000
Quarters > 3 > cash Flow > net Change In Cash
5281000
Quarters > 3 > ratios > PE
-4.100737971705714
Quarters > 3 > ratios > PB
0.5055245262075382
Quarters > 3 > ratios > ROE
-20.771779762001927
Quarters > 3 > ratios > ROA
-12.4253017224544
Quarters > 3 > ratios > FCF
-8458000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.633250311332503
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
3081000
Annuals > 0 > income Statement > gross Profit
-3081000
Annuals > 0 > income Statement > operating Expenses
70400000
Annuals > 0 > income Statement > operating Income
-70400000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-64767000
Annuals > 0 > income Statement > net Income
-64767000
Annuals > 0 > income Statement > eps
-21.444251303700025
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3020250
Annuals > 0 > income Statement > income Tax Expense
-1
Annuals > 0 > income Statement > EBITDA
-62086000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
5633000
Annuals > 0 > balance Sheet > cash
37573000
Annuals > 0 > balance Sheet > short Term Investments
39183000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
78815000
Annuals > 0 > balance Sheet > property Plant Equipment
23134000
Annuals > 0 > balance Sheet > total Assets
102412000
Annuals > 0 > balance Sheet > payables
742000
Annuals > 0 > balance Sheet > short Term Debt
3688000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
41151000
Annuals > 0 > balance Sheet > equity
61261000
Annuals > 0 > cash Flow > net Income
-64767000
Annuals > 0 > cash Flow > depreciation
3081000
Annuals > 0 > cash Flow > change In Working Capital
4204000
Annuals > 0 > cash Flow > cash From Operations
-47956000
Annuals > 0 > cash Flow > capital Expenditures
34000
Annuals > 0 > cash Flow > cash From Investing
54946000
Annuals > 0 > cash Flow > cash From Financing
8874000
Annuals > 0 > cash Flow > net Change In Cash
15864000
Annuals > 0 > ratios > PE
-21.444251303700025
Annuals > 0 > ratios > PB
0.3958898401919655
Annuals > 0 > ratios > ROE
-105.72305381890598
Annuals > 0 > ratios > ROA
-63.241612311057295
Annuals > 0 > ratios > FCF
-47990000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
29
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3721000
Annuals > 1 > income Statement > gross Profit
-3721000
Annuals > 1 > income Statement > operating Expenses
96415000
Annuals > 1 > income Statement > operating Income
-100136000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-102062000
Annuals > 1 > income Statement > net Income
-102062000
Annuals > 1 > income Statement > eps
-37.28768975028771
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2737150
Annuals > 1 > income Statement > income Tax Expense
5390000
Annuals > 1 > income Statement > EBITDA
-98341000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1926000
Annuals > 1 > balance Sheet > cash
21709000
Annuals > 1 > balance Sheet > short Term Investments
92585000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
117959000
Annuals > 1 > balance Sheet > property Plant Equipment
32153000
Annuals > 1 > balance Sheet > total Assets
150545000
Annuals > 1 > balance Sheet > payables
1298000
Annuals > 1 > balance Sheet > short Term Debt
3373000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
39262000
Annuals > 1 > balance Sheet > equity
111283000
Annuals > 1 > cash Flow > net Income
-102062000
Annuals > 1 > cash Flow > depreciation
3721000
Annuals > 1 > cash Flow > change In Working Capital
5339000
Annuals > 1 > cash Flow > cash From Operations
-78264000
Annuals > 1 > cash Flow > capital Expenditures
146000
Annuals > 1 > cash Flow > cash From Investing
65237000
Annuals > 1 > cash Flow > cash From Financing
135000
Annuals > 1 > cash Flow > net Change In Cash
-12892000
Annuals > 1 > ratios > PE
-37.28768975028771
Annuals > 1 > ratios > PB
0.19750828518282218
Annuals > 1 > ratios > ROE
-91.71391856797534
Annuals > 1 > ratios > ROA
-67.79501145836792
Annuals > 1 > ratios > FCF
-78410000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
3679000
Annuals > 2 > income Statement > gross Profit
-3679000
Annuals > 2 > income Statement > operating Expenses
138394000
Annuals > 2 > income Statement > operating Income
-138394000
Annuals > 2 > income Statement > interest Expense
2269000
Annuals > 2 > income Statement > pretax Income
-136125000
Annuals > 2 > income Statement > net Income
-136125000
Annuals > 2 > income Statement > eps
-50.01927280704301
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2721451
Annuals > 2 > income Statement > income Tax Expense
731000
Annuals > 2 > income Statement > EBITDA
-131715000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2269000
Annuals > 2 > balance Sheet > cash
34601000
Annuals > 2 > balance Sheet > short Term Investments
155009000
Annuals > 2 > balance Sheet > receivables
4267000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
197044000
Annuals > 2 > balance Sheet > property Plant Equipment
42238000
Annuals > 2 > balance Sheet > total Assets
243549000
Annuals > 2 > balance Sheet > payables
4065000
Annuals > 2 > balance Sheet > short Term Debt
3275000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
42183000
Annuals > 2 > balance Sheet > equity
201366000
Annuals > 2 > cash Flow > net Income
-136125000
Annuals > 2 > cash Flow > depreciation
3679000
Annuals > 2 > cash Flow > change In Working Capital
-8491000
Annuals > 2 > cash Flow > cash From Operations
-118210000
Annuals > 2 > cash Flow > capital Expenditures
5274000
Annuals > 2 > cash Flow > cash From Investing
25199000
Annuals > 2 > cash Flow > cash From Financing
-1353000
Annuals > 2 > cash Flow > net Change In Cash
-94364000
Annuals > 2 > ratios > PE
-50.01927280704301
Annuals > 2 > ratios > PB
0.108525031683601
Annuals > 2 > ratios > ROE
-67.6007866273353
Annuals > 2 > ratios > ROA
-55.89224344998337
Annuals > 2 > ratios > FCF
-123484000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1543000
Annuals > 3 > income Statement > gross Profit
-1543000
Annuals > 3 > income Statement > operating Expenses
185729000
Annuals > 3 > income Statement > operating Income
-185729000
Annuals > 3 > income Statement > interest Expense
343000
Annuals > 3 > income Statement > pretax Income
-185386000
Annuals > 3 > income Statement > net Income
-185386000
Annuals > 3 > income Statement > eps
-69.50584883023396
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2667200
Annuals > 3 > income Statement > income Tax Expense
6114000
Annuals > 3 > income Statement > EBITDA
-176186000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
343000
Annuals > 3 > balance Sheet > cash
128965000
Annuals > 3 > balance Sheet > short Term Investments
186808000
Annuals > 3 > balance Sheet > receivables
6204000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
325066000
Annuals > 3 > balance Sheet > property Plant Equipment
23806000
Annuals > 3 > balance Sheet > total Assets
355076000
Annuals > 3 > balance Sheet > payables
9448000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
36419000
Annuals > 3 > balance Sheet > equity
318657000
Annuals > 3 > cash Flow > net Income
-185386000
Annuals > 3 > cash Flow > depreciation
1543000
Annuals > 3 > cash Flow > change In Working Capital
11420000
Annuals > 3 > cash Flow > cash From Operations
-126879000
Annuals > 3 > cash Flow > capital Expenditures
25642000
Annuals > 3 > cash Flow > cash From Investing
-45814000
Annuals > 3 > cash Flow > cash From Financing
166656000
Annuals > 3 > cash Flow > net Change In Cash
-6037000
Annuals > 3 > ratios > PE
-69.50584883023396
Annuals > 3 > ratios > PB
0.06721213091192096
Annuals > 3 > ratios > ROE
-58.177287804755586
Annuals > 3 > ratios > ROA
-52.21023104912751
Annuals > 3 > ratios > FCF
-152521000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-2.4453025671416846
Valuation > metrics > PB
1.016258076478149
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-24.900385604113108
Profitability > metrics > ROA
-13.904539745200072
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.3830334190231361
Risk > metrics > Interest Coverage
-27.919354838709676
Risk > final Score
-82
Risk > verdict
High
Liquidity > metrics > Current Ratio
12.400979083222074
Liquidity > metrics > Quick Ratio
12.400979083222074
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-177
Prev Risks > 1
11
Prev Risks > 2
-88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T01:11:08.336Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-2.44
Earnings History > 0 > eps Estimate
-0.2
Earnings History > 0 > eps Difference
-2.24
Earnings History > 0 > surprise Percent
-1120
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-07-31
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.96
Earnings History > 1 > eps Estimate
-0.202
Earnings History > 1 > eps Difference
-2.758
Earnings History > 1 > surprise Percent
-1365.3465
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.25
Earnings History > 2 > eps Estimate
-0.2233
Earnings History > 2 > eps Difference
-0.0267
Earnings History > 2 > surprise Percent
-11.957
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-03
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
-0.2
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
0
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.2355
Earnings History > 4 > eps Estimate
-0.23
Earnings History > 4 > eps Difference
-0.0055
Earnings History > 4 > surprise Percent
-2.3913
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-08
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.26
Earnings History > 5 > eps Estimate
-0.31
Earnings History > 5 > eps Difference
0.05
Earnings History > 5 > surprise Percent
16.129
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.3
Earnings History > 6 > eps Estimate
-0.36
Earnings History > 6 > eps Difference
0.06
Earnings History > 6 > surprise Percent
16.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-04
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.3
Earnings History > 7 > eps Estimate
-0.4
Earnings History > 7 > eps Difference
0.1
Earnings History > 7 > surprise Percent
25
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.49
Earnings History > 8 > eps Estimate
-0.46
Earnings History > 8 > eps Difference
-0.03
Earnings History > 8 > surprise Percent
-6.5217
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-07
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.44
Earnings History > 9 > eps Estimate
-0.48
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
8.3333
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.63
Earnings History > 10 > eps Estimate
-0.5
Earnings History > 10 > eps Difference
-0.13
Earnings History > 10 > surprise Percent
-26
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-06
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.49
Earnings History > 11 > eps Estimate
-0.52
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
5.7692
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-10
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.49
Earnings History > 12 > eps Estimate
-0.79
Earnings History > 12 > eps Difference
0.3
Earnings History > 12 > surprise Percent
37.9747
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-04
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.73
Earnings History > 13 > eps Estimate
-0.83
Earnings History > 13 > eps Difference
0.1
Earnings History > 13 > surprise Percent
12.0482
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.79
Earnings History > 14 > eps Estimate
-0.89
Earnings History > 14 > eps Difference
0.1
Earnings History > 14 > surprise Percent
11.236
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-03
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.95
Earnings History > 15 > eps Estimate
-0.89
Earnings History > 15 > eps Difference
-0.06
Earnings History > 15 > surprise Percent
-6.7416
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.87
Earnings History > 16 > eps Estimate
-0.86
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-1.1628
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.9
Earnings History > 17 > eps Estimate
-0.76
Earnings History > 17 > eps Difference
-0.14
Earnings History > 17 > surprise Percent
-18.4211
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-05
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.76
Earnings History > 18 > eps Estimate
-0.74
Earnings History > 18 > eps Difference
-0.02
Earnings History > 18 > surprise Percent
-2.7027
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-03
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.85
Earnings History > 19 > eps Estimate
-0.7
Earnings History > 19 > eps Difference
-0.15
Earnings History > 19 > surprise Percent
-21.4286
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-10
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.63
Earnings History > 20 > eps Estimate
-0.76
Earnings History > 20 > eps Difference
0.13
Earnings History > 20 > surprise Percent
17.1053
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-13
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.6
Earnings History > 21 > eps Estimate
-0.57
Earnings History > 21 > eps Difference
-0.03
Earnings History > 21 > surprise Percent
-5.2632
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-11
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-1
Earnings History > 22 > eps Estimate
-0.45
Earnings History > 22 > eps Difference
-0.55
Earnings History > 22 > surprise Percent
-122.2222
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-28
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.69
Earnings History > 23 > eps Estimate
-0.69
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
0
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABehavioral Patterns of PASG and Institutional Flows news.stocktradersdaily.com
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$39.6
Analyst Picks
Strong Buy
5
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 46.38% of the total shares of Passage Bio Inc
1.
Orbimed Advisors, LLC(11.0652%)
since
2025/03/31
2.
Vestal Point Capital LP(9.5951%)
since
2025/03/31
3.
New Leaf Venture Partners, L.L.C.(3.9291%)
since
2025/03/31
4.
Erste Asset Management GmbH(3.8629%)
since
2025/03/31
5.
Vanguard Group Inc(3.2585%)
since
2025/03/31
6.
TANG CAPITAL MANAGEMENT LLC(2.3594%)
since
2025/03/31
7.
Vanguard Total Stock Mkt Idx Inv(2.3038%)
since
2025/07/31
8.
Renaissance Technologies Corp(2.2183%)
since
2025/03/31
9.
BlackRock Inc(1.1301%)
since
2025/03/31
10.
Geode Capital Management, LLC(0.859%)
since
2025/03/31
11.
Vanguard Institutional Extnd Mkt Idx Tr(0.8049%)
since
2025/07/31
12.
Bridgeway Capital Management, LLC(0.7961%)
since
2025/03/31
13.
Bridgeway Ultra-Small Company(0.6544%)
since
2025/06/30
14.
Galileo - Biotech Innovation Fund S USD(0.6485%)
since
2025/02/28
15.
Fidelity Extended Market Index(0.4529%)
since
2025/07/31
16.
Fiduciary Trust Co(0.3382%)
since
2025/03/31
17.
State Street Corp(0.2466%)
since
2025/03/31
18.
RBF LLC(0.2246%)
since
2025/03/31
19.
Millennium Management LLC(0.2143%)
since
2025/03/31
20.
Northern Trust Corp(0.1761%)
since
2025/03/31
21.
SIMPLEX TRADING, LLC(0.1295%)
since
2025/03/31
22.
Fidelity Total Market Index(0.1279%)
since
2025/07/31
23.
Extended Equity Market Fund K(0.1146%)
since
2025/06/30
24.
Fidelity Series Total Market Index(0.1119%)
since
2025/07/31
25.
Spartan Extended Market Index Pool F(0.0955%)
since
2025/07/31
26.
NT Ext Equity Mkt Idx Fd - L(0.093%)
since
2025/06/30
27.
Northern Trust Extended Eq Market Idx(0.093%)
since
2025/06/30
28.
NT Ext Equity Mkt Idx Fd - NL(0.083%)
since
2025/06/30
29.
Two Sigma Investments LLC(0.0739%)
since
2025/03/31
30.
XTX Topco Ltd(0.0714%)
since
2025/03/31
31.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0645%)
since
2025/06/30
32.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.0487%)
since
2024/12/31
33.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0262%)
since
2025/06/30
34.
UBS Group AG(0.0228%)
since
2025/03/31
35.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0222%)
since
2024/12/31
36.
Mariner Wealth Advisors LLC(0.0188%)
since
2025/03/31
37.
U.S. Equity Market Fund F(0.0177%)
since
2025/06/30
38.
Extended Equity Market Fund M(0.0144%)
since
2025/06/30
39.
Diversified Equity Fund F(0.01%)
since
2025/06/30
40.
SSgA U.S. Total Market Index Strategy(0.005%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-2.44
EPS Estimate
-0.2
EPS Difference
-2.24
Surprise Percent
-1120%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.